肺动脉高压患儿心脏骤停的结局与特征:ICU-RESUS临床试验的二次分析
该研究为ICU-RESUS临床试验(NCT02837497)的前瞻性设计二次分析,纳入1276例儿科院内心脏骤停(IHCA)患者中的1129例索引IHCA事件,其中184例(16.3%)存在骤停前肺动脉高压(PH)诊断,且101/184(54.9%)在IHCA时正在接受吸入一氧化氮治疗。主要生存结局为存活至出院且神经功能良好(儿科脑功能分类评分1-3分或较基线未变化),PH组与非PH组在单因素分析(48.9% vs 54.4%;p=0.17)和多因素分析(aOR 0.82 [95%CI: 0.56, 1.20];p=0.32)中均无显著差异。CPR事件结局、存活至出院率以及CPR期间平均舒张压、收缩压和呼气末二氧化碳在两组间均无显著差异。作者结论认为,骤停前PH诊断与生存结局或骤停期间生理指标无统计学显著差异。
要点
- 在1129例儿科IHCA中,184例(16.3%)存在骤停前肺动脉高压(PH)诊断,其中101/184(54.9%)在IHCA时正在接受吸入一氧化氮治疗。
- PH组与非PH组存活至出院且神经功能良好预后无显著差异:单因素分析48.9% vs 54.4%(p=0.17),多因素分析aOR 0.82(95%CI: 0.56, 1.20;p=0.32)。
- CPR事件结局和存活至出院率在PH组与非PH组间均无显著差异。
- CPR期间平均舒张压、收缩压和呼气末二氧化碳在PH组与非PH组间均无显著差异。
适用人群与场景
- 纳入ICU-RESUS临床试验的儿科院内心脏骤停(IHCA)患者,共1129例索引IHCA事件。
- 暴露因素为骤停前肺动脉高压(PH)诊断,184例(16.3%)存在PH。
研究设计与关键结果
- 研究类型:ICU-RESUS临床试验(NCT02837497)的前瞻性设计二次分析。
- 样本量:1276例患者中纳入1129例索引IHCA事件,其中184例(16.3%)有骤停前PH诊断,101/184(54.9%)在IHCA时接受吸入一氧化氮治疗。
- 主要生存结局(存活至出院且神经功能良好,儿科脑功能分类评分1-3分或较基线未变化):PH组48.9% vs 非PH组54.4%(单因素分析p=0.17);多因素分析aOR 0.82(95%CI: 0.56, 1.20;p=0.32)。
- CPR事件结局和存活至出院率在两组间无显著差异。
- CPR期间平均舒张压、收缩压和呼气末二氧化碳在两组间无显著差异。
证据类型、等级与局限
- 证据类型:前瞻性设计二次分析(基于ICU-RESUS临床试验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,骤停前肺动脉高压诊断与生存结局或骤停期间生理指标无统计学显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous studies have identified pulmonary hypertension (PH) as a relatively common diagnosis in children with in-hospital cardiac arrest (IHCA), and preclinical laboratory studies have found poor outcomes and low systemic blood pressures during CPR for PH-associated cardiac arrest. The objective of this study was to determine the prevalence of PH among children with IHCA and the association between PH diagnosis and intra-arrest physiology and survival outcomes.
METHODS: This was a prospectively designed secondary analysis of patients enrolled in the ICU-RESUS clinical trial (NCT02837497). The primary exposure was a pre-arrest diagnosis of PH. The primary survival outcome was survival to hospital discharge with favorable neurologic outcome (Pediatric Cerebral Performance Category score 1-3 or unchanged from baseline). The primary physiologic outcome was event-level average diastolic blood pressure (DBP) during CPR.
RESULTS: Of 1276 patients with IHCAs during the study period, 1129 index IHCAs were enrolled; 184 (16.3%) had PH and 101/184 (54.9%) were receiving inhaled nitric oxide at the time of IHCA. Survival with favorable neurologic outcome was similar between patients with and without PH on univariate (48.9% vs. 54.4%; p = 0.17) and multivariate analyses (aOR 0.82 [95%CI: 0.56, 1.20]; p = 0.32). There were no significant differences in CPR event outcome or survival to hospital discharge. Average DBP, systolic BP, and end-tidal carbon dioxide during CPR were similar between groups.
CONCLUSIONS: In this prospective study of pediatric IHCA, pre-existing PH was present in 16% of children. Pre-arrest PH diagnosis was not associated with statistically significant differences in survival outcomes or intra-arrest physiologic measures.
参考来源
- Morgan RW, Reeder RW, Ahmed T, et al. Outcomes and characteristics of cardiac arrest in children with pulmonary hypertension: A secondary analysis of the ICU-RESUS clinical trial. Resuscitation. 2023. PMID: 37406760. doi:10.1016/j.resuscitation.2023.109897
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。